LECITHIN-CHOLESTEROL ACYLTRANSFERASE DEFICIENCY

Course overview

LECITHIN CHOLESTEROL ACYLTRANSFERASE (LCAT) DEFICIENCY IS A RARE AUTOSOMAL RECESSIVE DISORDER IN LIPID METABOLISM, MANIFESTING FROM EARLY CHILDHOOD THROUGH ADULTHOOD. DIMINISHED HDL LEVELS AND THE ACCUMULATION OF CHOLESTEROL ACROSS VARIOUS TISSUES CHARACTERIZE THIS CONDITION. THE CONDITION EXHIBITS 2 DISTINCT CLINICAL PHENOTYPES, WITH COMPLICATIONS SUCH AS RENAL DYSFUNCTION AND CORNEAL OPACIFICATION CONTINGENT UPON THE SPECIFIC PHENOTYPE. THIS ACTIVITY REVIEWS THE CHARACTERISTICS OF THE DISEASE, ITS UNDERLYING PATHOPHYSIOLOGY, AND EFFECTIVE MANAGEMENT STRATEGIES AIMED AT CURTAILING DISEASE PROGRESSION. EMPHASIS IS PLACED ON THE CRITICAL NEED FOR TIMELY IDENTIFICATION OF THE DISEASE AND THE PROACTIVE MANAGEMENT OF ASSOCIATED COMPLICATIONS. THE COLLABORATIVE EFFORTS OF A COMPREHENSIVE, INTERPROFESSIONAL TEAM ARE PIVOTAL IN OPTIMIZING PATIENT CARE.CLINICIANS PARTICIPATING IN THIS ACTIVITY CAN EXPECT TO GAIN A COMPREHENSIVE UNDERSTANDING OF THIS RARE INHERITED SYNDROME. THE FOCUS INCLUDES INSIGHTS INTO THE PATHOLOGY INVOLVING THE PARTIAL OR COMPLETE ABSENCE OF LCAT ENZYME ACTIVITY, ITS IMPACT ON LIPID METABOLISM, AND THE RESULTING ABNORMAL LIPID PROFILES. PARTICIPANTS WILL ACQUIRE KNOWLEDGE CRUCIAL FOR DIAGNOSING, MANAGING, AND MITIGATING COMPLICATIONS RELATED TO IMPAIRED HDL METABOLISM.